Zixi Wang

ORCID: 0000-0001-8092-7073
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Ubiquitin and proteasome pathways
  • Mast cells and histamine
  • Immune cells in cancer
  • Immunodeficiency and Autoimmune Disorders
  • Corneal Surgery and Treatments
  • PI3K/AKT/mTOR signaling in cancer
  • Neuroblastoma Research and Treatments
  • Hematopoietic Stem Cell Transplantation
  • Chronic Lymphocytic Leukemia Research
  • Adenosine and Purinergic Signaling
  • interferon and immune responses
  • CAR-T cell therapy research
  • Drug Transport and Resistance Mechanisms

First Affiliated Hospital of Xi'an Jiaotong University
2023-2025

Ministry of Education of the People's Republic of China
2023

First Affiliated Hospital Zhejiang University
2023

Shenzhen Institutes of Advanced Technology
2022

Chinese Academy of Sciences
2022

University of Chinese Academy of Sciences
2022

Bioprocessing Technology Institute
2020-2021

Agency for Science, Technology and Research
2020-2021

National University of Singapore
2020-2021

Itaconate is a metabolite catalyzed by cis-aconitate decarboxylase (ACOD1), which mainly produced activated macrophages and secreted into the extracellular environment to exert complex bioactivity. In tumor microenvironment, itaconate concentrated induces an immunosuppressive response. However, whether can be taken up cells its mechanism of action remain largely unclear. Here, we identified solute carrier family 13 member 3 (SLC13A3) as key protein transporting cells, where it elevates...

10.1016/j.cmet.2024.11.012 article EN cc-by Cell Metabolism 2025-01-01

Natural killer (NK) cells are innate lymphocytes that directly kill tumor and pathogen-infected upon activation by cytokines NK cell receptors (NKRs) without previous sensitization. It is known metabolism affects the differentiation effector functions of immune cells. For instance, interleukin-2 interleukin-15 treatment increases glycolysis oxidative phosphorylation (OXPHOS) in to support their functions. However, little about metabolic reprogramming human NKRs. In this study, we...

10.3389/fimmu.2020.00202 article EN cc-by Frontiers in Immunology 2020-02-20

Abstract Natural killer (NK) cell‐based immunotherapy holds prominent potential for cancer treatment. However, its application in solid tumors is limited by a rapid decline viability and function, as well inadequate homing infiltration. Herein, generalized strategy offered to construct bio‐orthogonal targeted live‐cell nanocarrier (N 3 ‐NK‐NPs) coupling with responsive released interleukin‐21 (IL‐21) nanoparticles (ILNPs) on glyco‐engineered NK cell surfaces. Complementary groups (azide...

10.1002/adfm.202202603 article EN Advanced Functional Materials 2022-04-29

Cell metabolism plays a pivotal role in regulating the effector functions of immune cells. Stimulatory cytokines, such as interleukin (IL)-2 or IL-12 and IL-15, activate glycolysis oxidative phosphorylation natural killer (NK) cells to support their enhanced functions. IL-10, pleiotropic cytokine, is known suppress macrophage activation but stimulate NK However, it remains unclear if IL-10 has an effect on human so, what metabolic mechanisms are affected, how these changes regulated...

10.3389/fimmu.2021.619195 article EN cc-by Frontiers in Immunology 2021-02-23

Cyclic GMP-AMP synthase (cGAS) binds pathogenic and other cytoplasmic double-stranded DNA (dsDNA) to catalyze the synthesis of cyclic (cGAMP), which serves as secondary messenger activate STING pathway innate immune responses. Emerging evidence suggests that activation cGAS is crucial for anti-tumor immunity; however, no effective intervention method targeting currently available. Here we report palmitoylated by ZDHHC9 at cysteines 404/405, promotes dimerization cGAS. We further identified...

10.1016/j.molcel.2023.09.007 article EN cc-by Molecular Cell 2023-10-01

Abstract Inflammatory bowel disease (IBD) is driven by multiple genetic and environmental risk factors. Patients with mutations in Bruton’s tyrosine kinase (BTK) known to manifest high prevalence of intestinal disorders including IBD. Although BTK mediates the signaling various immune receptors, little how maintains homeostasis gut system. Here, we show that BTK-deficiency promotes IBD progression a mouse model colitis. Interestingly, increased colitis susceptibility BTK-deficient mice not...

10.1038/s41419-021-03702-y article EN cc-by Cell Death and Disease 2021-04-30
Coming Soon ...